Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Study of the Feasibility and Accuracy of DeepTRG for Automated Pathological Response Assessment After Neoadjuvant Therapy in Gastric and Gastroesophageal Junction Adenocarcinoma: A Single-Center Silent Validation Study

NCT07849608 is registered in ClinicalTrials.gov with Qun Zhao as lead sponsor.

NCT NCT07849608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07849608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Study of the Feasibility and Accuracy of DeepTRG for Automated Pathological Response Assessment After Neoadjuvant Therapy in Gastric and Gastroesophageal Junction Adenocarcinoma: A Single-Center Silent Validation Study
Lead sponsor
Qun Zhao
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2026
Completion date
December 30, 2026
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric adenocarcinoma, gastroesophageal junction adenocarcinoma